Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer

In this clinical trial, we investigated a novel noninvasive treatment option of stereotactic radiation therapy for the treatment of primary kidney cancer. We found that stereotactic radiation was safe and effective for the treatment of primary kidney cancers.

Read the full article here

Related Articles